Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
US11320416B1 · kind B1 · utility
4Cited by
76References
43Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 29, 2020 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | May 29, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2021/3595
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides methods of assessing suitability of a pharmaceutical composition for medical use. The pharmaceutical composition comprises nanoparticles comprising rapamycin coated with albumin and a non-nanoparticle portion comprising albumin and rapamycin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.